Docosahexaenoic Acid (DHA): benefits, dosage, contraindications
Other name(s)
Omega-3
Scientific name(s)
DHA, PUFA
Family or group:
Fatty Acids
Indications
Rating methodology
EFSA approval.
Eye health ✪✪✪✪✪
The EFSA (European Food Safety Authority) has concluded positively on DHA's contribution to maintaining normal vision. Published data suggest that infants not receiving DHA from breast milk or formula have delayed visual acuity development compared to those receiving adequate DHA. DHA is essential for normal neuronal function and plays a key role in developing neural and synaptic membranes, particularly retinal and visual functions. Moreover, studies show that taking omega 3 (DHA and EPA) can reduce the risk of developing AMD (age-related macular degeneration).
Posologie
Synergies
Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials
Comparative Analysis of Docosahexaenoic Acid (DHA) Content in Mother's Milk of Term and Preterm Mothers
Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA)
Are human milk long-chain polyunsaturated fatty acids related to visual and neural development in breast-fed term infants?
Effects of lutein and docosahexaenoic acid supplementation on macular pigment optical density in a randomized controlled trial
Child development ✪✪✪✪✪
The EFSA has published a positive opinion on DHA's contribution to maintaining normal brain functions in children and adults. Long-chain polyunsaturated fatty acids represent a third of all lipids in brain matter. Studies show that insufficient intake of polyunsaturated fatty acids like DHA during fetal and child development is considered a factor in developing behavioral, functional, and neurological disorders.
Posologie
Docosahexaenoic Acid (DHA): From the Maternal-Foetal Dyad to the Complementary Feeding Period
Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA)
Prenatal supplementation with DHA improves attention at 5 y of age: a randomized controlled trial
Dyslipidemia ✪✪✪✪✪
Clinical evidence suggests that taking 1.25 to 4 g of DHA per day for 7 weeks can reduce triglyceride levels by 17% to 24% in patients with dyslipidemia or hypertriglyceridemia. Most clinical research suggests that DHA neither decreases total cholesterol nor HDL cholesterol (high-density lipoproteins).
Posologie
Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial.
Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
Effects of dietary eicosapentaenoic acid and docosahexaenoic acid supplementation on metabolic syndrome: A systematic review and meta-analysis of data from 33 randomized controlled trials
Pregnancy ✪✪✪✪✪
DHA is present in human breast milk and found in the plasma and cerebral cortex of infants. Pregnancy can lead to long-term effects on DHA stores in women. However, maternal DHA levels likely normalize within one year after pregnancy. There appears to be a preferential transfer of DHA through the placenta. Maternal DHA supplementation at 200 mg/day from the 15th week of pregnancy or during the third trimester might normalize DHA levels in the mother. Maternal DHA levels tend to decrease significantly during the third trimester of pregnancy. Omega 3 supplementation, particularly DHA, could prevent some pregnancy-related complications like hypertension or eclampsia. High-quality clinical studies show that DHA supplementation also reduces the risk of premature birth.
Posologie
Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings
DHA supplementation and pregnancy outcomes.
Docosahexaenoic acid (DHA) intake estimated from a 7-question survey identifies pregnancies most likely to benefit from high-dose DHA supplementation
A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery
Maternal docosahexaenoic acid supplementation and fetal accretion
Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomized, double-blind, adaptive-design superiority trial
Early and late preterm birth rates in participants adherent to randomly assigned high dose docosahexaenoic acid (DHA) supplementation in pregnancy
Effect of fish oil supplementation in pregnancy on bone, lean, and fat mass at six years: randomized clinical trial.
Effect of placental function on fatty acid requirements during pregnancy
Omega-3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy.
Fetal Development ✪✪✪✪✪
DHA accumulates rapidly in the human brain during the third trimester of pregnancy and early postnatal period. The accumulation of DHA and other fatty acids at this stage leads to rapid development and growth of brain tissue. Furthermore, some data suggest that infants who do not receive DHA in breast milk have delayed visual acuity development compared to those who receive an adequate amount of DHA.
Posologie
Docosahexaenoic Acid (DHA): From the Maternal-Fetal Dyad to the Complementary Feeding Period
Fetal DHA inadequacy and the impact on child neurodevelopment: a follow-up of a randomized trial of maternal DHA supplementation in pregnancy
Effect of fish oil supplementation in pregnancy on bone, lean, and fat mass at six years: randomized clinical trial.
Omega-3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy.
Dementia ✪✪✪✪✪
Studies have shown that an increase of 0.1 g per day in dietary DHA intake was associated with a 14% reduced risk of dementia when taken over 2 to 21 years. However, no dose-response relationship was found. Other clinical studies suggest that taking 0.72 grams of DHA per day for one year improves dementia symptoms in patients with dementia due to cerebral vascular thrombosis. Preliminary clinical research conducted on patients with mild to moderate Alzheimer's disease shows that taking 500 mg of DHA daily in fish oil combined with carotenoids (Lutein and Zeaxanthin) for 12 months slightly improved memory and mood compared to placebo. According to researchers, oxidized derivatives of DHA are involved in Alzheimer's disease. DHA seems to be a target of oxidative attack in this disease. Without certainty on the cause-effect relationship of oxidation in Alzheimer's disease, it is recommended to protect DHA reserves in the brain with DHA supplementation associated with antioxidants like vitamin E.
Posologie
Synergies
Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease
Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease: The Framingham Heart Study
Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies.
Cognitive Decline ✪✪✪✪✪
Preliminary clinical studies show that taking 12 mg of lutein, alone or with docosahexaenoic acid (DHA), at 800 mg per day for 4 months, can improve verbal fluency and memory scores compared to baseline levels in older women. Another randomized double-blind placebo-controlled trial showed that oral DHA supplementation (2 g/day) for 12 months in older subjects with mild cognitive impairment had a beneficial effect on overall cognitive function. Results suggest that DHA supplementation over 12 months significantly increased hippocampal volume. The hippocampus is a brain region essential for memory formation and plays a significant role in the consolidation of information from short-term memory to long-term memory and spatial navigation.
Posologie
Synergies
Effects of DHA Supplementation on Hippocampal Volume and Cognitive Function in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial
Cognitive Decline and Fatty Acid Composition of Erythrocyte membranes--The EVA Study
The effects of docosahexaenoic acid supplementation on cognition and well-being in mild cognitive impairment: A 12-month randomised controlled trial
Beneficial Effects of Docosahexaenoic Acid on Cognition in Age-Related Cognitive Decline
Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial
Coronary Heart Disease ✪✪✪✪✪
Increased dietary intake of DHA may reduce the risk of death in patients with coronary heart disease. It is noted that studies emphasize a cardioprotective effect, but no effect on atherosclerosis progression. The probable explanation is that omega-3s modulate the heart's electrical activity and produce a "stabilizing" effect that protects in case of a heart attack.
Posologie
Synergies
AMD ✪✪✪✪✪
Increased dietary intake of DHA is associated with a reduced risk of AMD. Preliminary clinical research shows that taking a combination of DHA 280 mg, lutein 12 mg, and zeaxanthin 0.6 mg per day for one year increases macular pigment optical density by 31% compared to placebo in patients with AMD. An increase in macular pigment optical density is associated with improved visual performance and a lower risk of AMD.
Posologie
Synergies
Prospective study of dietary fat and the risk of age-related macular degeneration
Nutrition and the aging retina: A comprehensive review of the relationship between nutrients and their role in age-related macular degeneration and retina disease prevention
Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial
Properties
Neurological
In healthy subjects, DHA increases the activation of the prefrontal cortex during sustained attention. In animals, DHA injection shortly after a spinal cord injury, followed by the addition of DHA in the diet, provides neuroprotective effects, notably increasing the survival of glial cells responsible for protecting neural tissue. In vitro research suggests that neuroprotectin D1 - a DHA-derived mediator - enhances inflammatory signaling and neuronal dysfunctions linked to beta-amyloid peptides (a small protein detrimental to the central nervous system under certain circumstances like in Alzheimer's disease). Laboratory and animal research also suggests that DHA levels in the brain regulate glucose uptake by acting on glucose transporters.
Usages associés
Vision
According to laboratory research, DHA plays a significant role in the development and maintenance of the retina, where DHA makes up 60% of polyunsaturated fatty acids. Laboratory research suggests that neuroprotectin D1 - a DHA-derived mediator - may counteract aging or degeneration of retinal pigment epithelial cells and photoreceptor cells.
Usages associés
Essential
There is interest in using DHA supplements for young children's development. Some data suggest that infants not receiving DHA from breast milk or formula lag in the development of visual acuity compared to those receiving enough. Long-chain polyunsaturated fatty acids make up a third of all brain matter lipids. DHA is regarded as important for normal neuron function and might play a key role in the structural development of neuronal and synaptic membranes. DHA rapidly accumulates in the human brain during the third trimester of pregnancy and early postnatal period. This accumulation leads to rapid brain tissue development and growth. Insufficient availability of polyunsaturated fatty acids like DHA during fetal and infant development is considered a factor behind behavioral, functional, and neurological disorders. Higher plasma DHA levels during childbirth may also be associated with greater newborns' central nervous system maturity, based on sleep and waking habits.
Usages associés
Hypolipidemic
DHA appears to reduce serum triglycerides. However, it does not increase HDL cholesterol (high-density lipoproteins, good cholesterol) in most studies, although it may increase HDL-2 fractions in some studies. DHA does not appear to decrease total cholesterol.
Usages associés
Anti-inflammatory
The anti-inflammatory effects associated with DHA may be linked to its metabolites serving as messengers. Indeed, resolvins (derived from DHA) may affect inflammatory mediators and inflammatory cells. Omega 3 can partially replace arachidonic acid (AA) - a pro-inflammatory omega 6 derivative - as they compete with AA for necessary synthesis enzymes like cyclooxygenase (COX). For the record, COX is an enzyme targeted by aspirin - a famous non-steroidal anti-inflammatory- to reduce inflammation.
Cardiovascular
DHA appears to reduce blood viscosity and increase red blood cell deformability, helping to prevent thrombosis. Various clinical trials have shown that DHA can reduce blood pressure. Although the mechanism is unclear, DHA seems to improve blood vessel dilation in men with hyperlipidemia, but not in healthy young adults.
Usages associés
Safety dosage
Adult from 18 year(s) : 250 mg - 3000 mg (oil)
The minimum physiological requirement for DHA is 250 mg per day for adults.
Child from 2 to 18 year(s) : 250 mg (oil)
Foods intended for children aged 2 to 18 years should provide a daily intake of 250 mg of DHA in one or more servings.
Infant from 6 to 24 months : 100 mg (oil)
Foods intended for infants aged 6 months to 2 years should provide a daily intake of 100 mg of DHA in one or more servings.
Pregnant woman : 250 mg - 450 mg (oil)
Breastfeeding woman: 250 mg - 450 mg (oil)
Interactions
Médicaments
Antidiabetic: moderate interaction
DHA appears to increase fasting blood glucose in subjects with type 2 diabetes. Theoretically, DHA may interfere with antidiabetic medications and reduce their effects.
Antihypertensive: moderate interaction
Fish oils containing DHA may lower blood pressure and have additive effects in patients treated with antihypertensive medications.
Plantes ou autres actifs
Docosahexaenoic acid (DHA): weak interaction
Omega 3s may reduce selenium absorption.